ClostraBio
Business Services · Illinois, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
1452 E 53rd St, Chicago, Illinois, 60615...Website
www.clostrabio.comRevenue
<$5 MillionIndustry
About ClostraBio
ClostraBio Org Chart
Is ClostraBio your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if ClostraBio is spiking on competitors!
Funding: Get notified immidiatlly once ClostraBio has new funding data
Click to see if ClostraBio had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at ClostraBio
Product Launch: Get notified when ClostraBio launches new products
ClostraBio, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Check if ClostraBio has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on ClostraBio recently announced quarterly report
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to ClostraBio
Compare insights from companies similar to ClostraBio, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
ClostraBio is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
ClostraBio is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about ClostraBio.
ClostraBio Tech Stack
A closer look at the technologies used by ClostraBio
Most Recent Scoops
ClostraBio News & Media
ClostraBio Announces Breakthrough Publication Describing Targeted Delivery of Metabolite to Gastrointestinal Tract via Oral Nanoparticles; Appoints CEO
CHICAGO--(BUSINESS WIRE)--ClostraBio, a biotech company focused on developing novel therapeutic solutions for diseases of the gut, is excited to announce a major breakthrough in targeted metabolite delivery to transform intestinal health. This first-in-class, oral, targeted metabolite delivery platform enables butyrate to achieve its maximum therapeutic potential with an initial focus on helping patients who struggle with gastrointestinal issues like mild to moderate ulcerative colitis and foodStartup targeting food allergies raises more funding | Crain's Chicago Business
With roots at the U of C, ClostraBio lands $4 million for its therapy in development to alleviate the effects of food allergies and ulcerative colitis.ClostraBio will present at the 14th Annual Biotech Showcase Event
ClostraBio will share updates on a compound in development for ulcerative colitis and food allergy and start of Series A investment round at Biotech Showcase™ 2022 (PRWeb January 10, 2022) Read the full story at https://www.prweb.com/releases/clostrabio_will_present_at_the_14th_annual_biotech_showcase_event/prweb18422533.htm
Top Business Services Companies
Frequently Asked Questions Regarding ClostraBio
ClostraBio, Inc. is dedicated to developing new dietary supplements and therapeutics targeting gut health, inflammatory bowel disease (IBD), and food allergies. Their focus is on delivering bacterial metabolites to improve intestinal health through a plug-n-play platform. The company's team consists of respected scientists and entrepreneurs special... Read More